Attached files
| file | filename |
|---|---|
| EX-99.1 - Vyteris Holdings (Nevada), Inc. | v174648_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
report (Date of earliest event reported): February 11, 2010
VYTERIS,
INC.
(Exact
Name of Registrant as Specified in its Charter)
|
Nevada
|
000-32741
|
84-1394211
|
|
(State
or Other Jurisdiction of Incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
13-01
Pollitt Drive, Fair Lawn, NJ
|
07410
|
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
Registrant’s telephone
number, including area code (201) 703-2299
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
5.02. Election of a New Director
Effective
February 11, 2010, Eugene A. Bauer, M.D. has been elected as a Director and
Chairman of the Board of Directors of Vyteris, Inc. (the “Company”) by the Board
of Directors.
Dr. Bauer
is the President and Chief Medical Officer of Peplin Inc., the US-based
subsidiary of LEO Pharma, and was a co-founder of Connetics, a publicly-traded
biotechnology company that was acquired by Stiefel Laboratories in
2006. He is a former Dean of the School of Medicine at Stanford
University. Dr. Bauer was previously Chief Executive Officer of
Neosil Inc., which was acquired by Peplin in 2008. Dr. Bauer is Lucy
Becker Professor, Emeritus, in the School of Medicine at Stanford University, a
position he has held since 2002. He served as Vice President for
Medical Affairs and Dean of the Stanford University School of Medicine from 1995
to 2001 and served as Chair of the Department of Dermatology at the Stanford
University School of Medicine from 1988 to 1995. During his tenure as
department chair, Dr. Bauer also served as Program Director
of the Stanford University General Clinical Research Center (GCRC), where he
oversaw the federal and industry-sponsored research carried out in the
GCRC. In addition, Dr. Bauer is a member of the board of
directors of Medgenics, Inc., Arbor
Vita Corp., Patient Safety Technologies, Inc., and MediSync
Bioservices.
There
were no arrangements between Dr. Bauer and any third persons, pursuant to which
he was selected as a Director. There has been no determination as to
which Board Committees, if any, Dr. Bauer will be appointed. In
connection with his appointment, Dr. Bauer is granted 727,549 options to
purchase common stock of the Company, which vest quarterly over two
years. Dr. Bauer will receive other compensation as set forth in the
Company’s Outside Director Plans.
Item
9.01 Financial Statements and Exhibits
The
following Exhibits are attached to this Current Report:
|
99.1
|
Press
release dated February 17, 2010
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
VYTERIS,
INC.
|
||||
|
By:
|
/s/
Joseph Himy
|
|||
|
Name:
Joseph Himy
|
||||
|
Title:
Chief Financial Officer
|
||||
|
Dated: February
17, 2010
|
||||